Genomic response to interferon-α in chimpanzees: Implications of rapid downregulation for hepatitis C kinetics†

作者: Robert E. Lanford , Bernadette Guerra , Helen Lee , Deborah Chavez , Kathleen M. Brasky

DOI: 10.1002/HEP.21167

关键词:

摘要: The mechanism of the interferon-alpha (IFN-alpha)-induced antiviral response during hepatitis C virus (HCV) therapy is n o t completely understood. In this study,we examined transcriptional to IFN-alpha in uninfected chimpanzees after single doses chimpanzee, human, or human-pegylated IFN-alpha. Liver and peripheral blood mononuclear cell (PBMC) samples were used for total genome microarray analysis. Most induced genes achieved maximal within 4 hours, began decline by 8 at baseline levels 24 hours postinoculation, a time when high circulating pegylated still present. rapid downregulation may be involved transition between observed phase I II viral kinetics HCV-infected patients. all three forms was similar; thus, reasons previous failures treatment with human not due species specificity partially tissue-specific. A 1778 altered expression twofold more IFN-alpha, 538 950 being unique liver PBMC, respectively. Analysis IFN-gamma responses primary chimpanzee hepatocytes compared as well. overlapping sets hepatocytes. conclusion, largely tissue-specific, rapidly downregulated vivo, which have significant influence on response.

参考文章(51)
A C Larner, A Chaudhuri, J E Darnell, Transcriptional induction by interferon: new protein(s) determine the extent and length of the induction Journal of Biological Chemistry. ,vol. 261, pp. 453- 459 ,(1986) , 10.1016/S0021-9258(17)42492-6
Kirsten L. Hokeness, William A. Kuziel, Christine A. Biron, Thais P. Salazar-Mather, Monocyte Chemoattractant Protein-1 and CCR2 Interactions Are Required for IFN-α/β-Induced Inflammatory Responses and Antiviral Defense in Liver Journal of Immunology. ,vol. 174, pp. 1549- 1556 ,(2005) , 10.4049/JIMMUNOL.174.3.1549
Robert E Lanford, Deborah Chavez, Lena Notvall, Kathleen M Brasky, Comparison of tamarins and marmosets as hosts for GBV-B infections and the effect of immunosuppression on duration of viremia. Virology. ,vol. 311, pp. 72- 80 ,(2003) , 10.1016/S0042-6822(03)00193-4
Karla J. Helbig, Daryl T.-Y. Lau, Ljiljana Semendric, Hugh A. J. Harley, Michael R. Beard, Analysis of ISG expression in chronic hepatitis C identifies viperin as a potential antiviral effector. Hepatology. ,vol. 42, pp. 702- 710 ,(2005) , 10.1002/HEP.20844
G William Demers, Barry J Sugarman, Josefina C Beltran, Louis N Westreich, CM Iqbal Ahmed, Johnson Y Lau, Zhi Hong, Robert E Lanford, Daniel C Maneval, None, Interferon-α2b Secretion by Adenovirus-Mediated Gene Delivery in Rat, Rabbit, and Chimpanzee Results in Similar Pharmacokinetic Profiles Toxicology and Applied Pharmacology. ,vol. 180, pp. 36- 42 ,(2002) , 10.1006/TAAP.2002.9372
David L. Thomas, Leonard B. Seeff, Natural History of Hepatitis C Clinics in Liver Disease. ,vol. 9, pp. 383- 398 ,(2005) , 10.1016/J.CLD.2005.05.003
David E Levy, Isabelle J Marié, RIGging an antiviral defense--it's in the CARDs. Nature Immunology. ,vol. 5, pp. 699- 701 ,(2004) , 10.1038/NI0704-699
Alan S. Perelson, Eva Herrmann, Florence Micol, Stefan Zeuzem, New kinetic models for the hepatitis C virus Hepatology. ,vol. 42, pp. 749- 754 ,(2005) , 10.1002/HEP.20882